Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Dr. Agarwal’s Health Care Ltd. ( (IN:AGARWALEYE) ) has issued an announcement.
Dr. Agarwal’s Health Care Limited has disclosed that the independent Monitoring Agency, ICRA Limited, has confirmed there is no deviation in the company’s use of proceeds from its Initial Public Offer for the quarter ended December 31, 2025. The monitoring report, filed under SEBI regulations and made available on the company’s website, states that IPO funds have been utilized in line with the stated objects of the issue, reinforcing governance standards and offering reassurance to investors and regulators regarding the company’s capital deployment and compliance practices.
More about Dr. Agarwal’s Health Care Ltd.
Dr. Agarwal’s Health Care Limited operates in the healthcare sector, focusing on eye care services through its network of eye hospitals and clinics under the Dr. Agarwal’s brand. The company’s primary activities center on providing specialized ophthalmology treatments and related healthcare services to patients across its markets.
Average Trading Volume: 20,093
Technical Sentiment Signal: Strong Sell
Current Market Cap: 137.9B INR
Learn more about AGARWALEYE stock on TipRanks’ Stock Analysis page.